Patient-Centered Acupuncture for Pain (PCAP)

Patient-Centered Integration of Acupuncture to Decrease Pain for Cancer Survivors

The objective of this study is to find out if acupuncture can improve the management of pain in cancer patients when used as part of a treatment plan that includes conventional pain medications. The investigators will enroll 36 cancer patients at Abramson Cancer Center and Penn Cancer Network sites. Participants will be enrolled in either the Conventional Pain Management group or Integrative Pain Management group.

Study Overview

• Status: Completed
• Conditions: Cancer Survivors
• Intervention / Treatment: Behavioral: Survey

• Study Type: Observational
• Enrollment (Anticipated): 36

Contacts and Locations

Study Locations

• United States
  • Pennsylvania
    • Philadelphia, Pennsylvania, United States, 19104
      • Abramson Cancer Center of the University of Pennsylvania

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

Cancer survivors 18 years or older with pain ratings of 4 or greater on a 0-10 numerical rating scale; primary diagnosis of cancer (stages I-III); finished primary cancer treatment; Karnofsky score 60 or greater; and who have been taking pain medications daily.

Description

Inclusion Criteria:

• Women or men age 18 years or older
• Primary diagnosis of cancer with history of stage I, II, or III cancer
• Finished primary cancer treatments (surgery, chemotherapy, radiotherapy)
• Have a Karnofsky score of 60 or greater
• Can understand written English
• Have worst pain rated at least 4 or greater on an 11-point (0-10) numerical rating scale in the preceding week
• Have been taking pain medications daily
• Have had at least 15 days with pain in the preceding 30 days.

Exclusion Criteria:

• Women or men with metastatic (stage IV) cancer
• Unstable and progressive medical conditions as judged by the PIs or designated research nurse at the community hospitals (e.g., progressive cancer, uncontrolled heart failure) that may require hospitalization in the next 12 weeks
• Planned surgical procedures in the next 12 weeks
• Patients currently in a pain crisis as judged by the PI or designated research nurse that may warrant acute titration of medications or hospitalization
• Women who are pregnant or breastfeeding
• Unwillingness to adhere to study related procedures.

Study Plan

How is the study designed?

Design Details

• Time Perspectives: Prospective

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Cancer survivors	Behavioral: Survey

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Number of Adverse Events	12 weeks

Collaborators and Investigators

• Sponsor: Abramson Cancer Center of the University of Pennsylvania

Study record dates

Study Major Dates

• Study Start: May 1, 2014
• Primary Completion (Actual): January 1, 2015
• Study Completion (Actual): January 1, 2015

Study Registration Dates

• First Submitted: May 29, 2014
• First Submitted That Met QC Criteria: May 30, 2014
• First Posted (Estimate): June 2, 2014

Study Record Updates

• Last Update Posted (Estimate): January 14, 2015
• Last Update Submitted That Met QC Criteria: January 13, 2015
• Last Verified: January 1, 2015

More Information

Terms related to this study

• Other Study ID Numbers: UPCC 01914